Clinical Trials on Cyclooxygenase 2 Inhibitors in Finland
Total 405 results
-
Folkhälsan Researech CenterNärpes Health Care Center, Närpes, Finland; Department of Social Services and... and other collaboratorsCompleted
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation... and other collaboratorsUnknownType 2 Diabetes Mellitus | Healthy VolunteersFinland
-
Marja-Riitta TaskinenGöteborg UniversityCompletedType 2 Diabetes MellitusFinland
-
Abbott Diabetes CareRecruitingType 2 Diabetes Treated With InsulinFinland
-
University of OuluUniversity of Texas Southwestern Medical Center; Maastricht University; Finnish...Active, not recruitingType 2 DiabetesFinland
-
University of Eastern FinlandUnknown
-
Finnish Institute for Health and WelfareAcademy of FinlandCompleted
-
AstraZenecaAntaros Medical; Bioventure Hub; 43183 Mölndal; SwedenCompletedType 2 Diabetes MellitusFinland
-
VTT Technical Research Centre of FinlandCompletedHypertension | Diabetes Mellitus Type 2Finland
-
Kirsi PietiläinenTurku University Hospital; University of HelsinkiRecruitingType2 DiabetesFinland
-
Helsinki University Central HospitalGöteborg UniversityCompleted
-
University of Eastern FinlandUniversity of Oslo; Karolinska Institutet; University of Copenhagen; University... and other collaboratorsRecruitingPhysical Activity | Type2 Diabetes | Diet Habit | Life Style | EmpowermentFinland
-
Turku University HospitalSmithKline BeechamCompletedType 2 Diabetes | Insulin SensitivityFinland
-
Turku University HospitalLund UniversityCompletedObesity | Type 2 DiabetesFinland
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
AstraZenecaCompleted
-
Tampere University HospitalTampere UniversityEnrolling by invitation
-
Finnish Institute for Health and WelfareUniversity of Eastern Finland; University of Oulu; Finnish Diabetes AssociationActive, not recruiting
-
Turku University HospitalAntaros MedicalCompletedDiabetes Mellitus, Type 2Finland
-
Folkhälsan Researech CenterLund University; University of Padova; University of Pavia; Medtronic; Universidad... and other collaboratorsCompletedDiabetes Mellitus, Type 2Finland
-
Helsinki University Central HospitalUnknownDiabetes Mellitus, Type 2 | Anticoagulant DrugsFinland
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFinland
-
University of HelsinkiActive, not recruitingCardiovascular Diseases | Colorectal Cancer | Type2 DiabetesFinland
-
UKK InstituteUniversity of Eastern Finland; North Karelia Hospital DistrictUnknown
-
University of OuluOulu University HospitalCompleted
-
Helsinki University Central HospitalCompletedObesity | Metabolic Syndrome | Type 2 DiabetesFinland
-
University of TurkuFazer; Aromtech Ltd.; Pakkasmarja; Saarioinen; Kiantama Ltd.; Satakunta Sea Buckthorn... and other collaboratorsCompletedAtherosclerosis | Type 2 DiabetesFinland
-
Solvay PharmaceuticalsTerminatedType 2 Diabetes | DyslipidemiaFinland, Ireland, Italy
-
AstraZenecaTerminatedType 2 DiabetesItaly, Finland, United Kingdom
-
Sigrid Therapeutics ABCompletedOverweight | PreDiabetes | Prediabetic State | Type2 Diabetes | Obese | Type2 Diabetes Mellitus | Pre DiabetesFinland, Sweden
-
Tampere University HospitalTampere UniversityActive, not recruitingHyperglycemia | Diabetes Mellitus, Type 2 | Hypoglycemia | Cognitive Impairment | MoodFinland
-
Turku University HospitalUniversity of Turku; Kuopio University Hospital; University of Eastern FinlandRecruitingCardiovascular Diseases | Obesity | Diabetes Mellitus, Type 2 | Insulin Resistance | PreDiabetes | Lipid Metabolism DisordersFinland
-
Helsinki University Central HospitalPfizerEnrolling by invitationLiver Cirrhosis | Diabetes Mellitus, Type 2 | NAFLDFinland
-
Finnish Institute for Health and WelfareNorwegian Institute of Public Health; Karolinska InstitutetCompletedCovid19 | SARS-CoV-2 InfectionFinland
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
Paijat-Hame Hospital DistrictPfizer; Tampere University; Sitra, the Finnish Innovation FundUnknownHeart Failure | Coronary Disease | Diabetes Mellitus, Type 2Finland
-
Tampere University HospitalActive, not recruitingCOVID-19 | SARS-CoV-2 InfectionFinland
-
South Karelia, Social and Health Care DistrictCompletedCoronary Artery Disease | Heart Failure | Atrial Fibrillation | Type 2 Diabetes | Other ArrhythmiasFinland
-
Novo Nordisk A/SEnrolling by invitationDiabetes Mellitus, Type 2Finland, France
-
QuiOSHL Medical; MidMichigan HealthUnknown
-
Clinical Urology and Epidemiology Working GroupHelsinki University Central Hospital; Oulu University Hospital; Kuopio University... and other collaboratorsRecruitingCovid19 | Coronavirus Disease 2019 | SARS-CoV-2 Acute Respiratory DiseaseFinland
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
University of OuluOulu University Hospital; Juho Vainio Foundation; Yrjo Jahnsson FoundationCompletedObesity | Diabetes Mellitus, Type 2 | Anhedonia | HypercholesterolemiaFinland
-
Markus PerolaUniversity of Helsinki; Institute for Molecular MedicineActive, not recruitingType 2 Diabetes | Coronary Heart Disease | Deep Vein ThrombosisFinland
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
Rhode Island HospitalCompletedSmoking | Type 2 DiabetesUnited States
-
Rhode Island HospitalCompletedType 2 Diabetes | At-risk DrinkingUnited States
-
Helsinki University Central HospitalRecruitingMedial Epicondyle Fracture of the Humerus | 7 to16 Year Old Children and Adolecents | More Than 2 mm of DisplacementFinland